—
C+
C+ The full Closelooknet — membership. Open the C+ overview

Tempus AI, Inc. Class A Common Stock（TEM）— 同类公司组

数据截至2026-10-09 — 评分每个交易日晚间重新计算。分组标准＝首先为共同的Closelook指数成分，其次为行业。Closelook研究日记，不构成投资建议。

Tempus AI, Inc. Class A Common Stock的Closelook综合评分为39/100，在同类公司组内排名第9位（共9家）——组内评分最高的是Halozyme Therapeutics Inc（74/100）。

名称综合动量质量估值信号距52周高点
TEM Tempus AI, Inc. Class A Common Stock39731815neutral33.6%
HQY HealthEquity Inc61626846info13.9%
VEEV Veeva Systems Inc Class A60957331bull8.3%
HNGE Hinge Health, Inc.56946226ok0.4%
BTSG BrightSpring Health Services, Inc. Common Stock48652440ok13.6%
HALO Halozyme Therapeutics Inc74939451ok5.5%
BION.SW BB Biotech AG73589681info13.8%
DXCM DexCom Inc66818038watch8.8%
LLY Eli Lilly and Company64709129watch9.5%

评分为Closelook全部覆盖范围内的相对读数——方法论见公司评分说明。信号灯来自每日夜间信号看板。

FAQ · from the current data · as of 2026-10-09

Quick answers

Tempus AI, Inc. Class A Common Stock在Closelook覆盖范围内的同类公司有哪些？

分组首先基于共同的Closelook指数成分，其次基于行业：HealthEquity Inc (HQY)、Veeva Systems Inc Class A (VEEV)、Hinge Health, Inc. (HNGE)、BrightSpring Health Services, Inc. Common Stock (BTSG)、Halozyme Therapeutics Inc (HALO)、BB Biotech AG (BION.SW)、DexCom Inc (DXCM)、Eli Lilly and Company (LLY)。

TEM相对同类公司的评分如何？

Tempus AI, Inc. Class A Common Stock的综合评分为39/100，组内排名第9位（共9家），截至2026-10-09；组内最高综合评分为Halozyme Therapeutics Inc（74/100）。Closelook评分为研究日记读数，不构成评级或投资建议。

Related in the Closelooknet universe

then Health Information Services, then Healthcare. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.